Serotonin and norepinephrine reuptake inhibitor antidepressants: a look through the prism of their 30-year history

Serotonin and norepinephrine reuptake inhibitor antidepressants: a look through the prism of their 30-year history

Based on the data available in the literature, the author has first systematized in detail the main stages of the design and clinical introduction of serotonin and norepinephrine reuptake inhibitor (SNRI) antidepressants. Theoretical prerequisites for their emergence are described. The evaluation of...

Full description

Bibliographic Details
Main Author:	D. S. Danilov
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2018-12-01
Series:	Неврология, нейропсихиатрия, психосоматика
Subjects:	antidepressants serotonin and norepinephrine reuptake inhibitors dual-action antidepressants venlafaxine milnacipran duloxe-tine desvenlafaxine levomilnacipran clovoxamine sibutramine history of psychopharmacology history of psychopharmacotherapy
Online Access:	https://nnp.ima-press.net/nnp/article/view/990

Similar Items

New Serotonin-Norepinephrine Reuptake Inhibitors and Their Anesthetic and Analgesic Considerations
by: David Fanelli, et al.
Published: (2021-10-01)

Design and Synthesis of Arylamidine Derivatives as Serotonin/Norepinephrine Dual Reuptake Inhibitors
by: Hui Wen, et al.
Published: (2019-01-01)

In vitro, in vivo, and in silico approaches for evaluating the preclinical DMPK profiles of ammoxetine, a novel chiral serotonin and norepinephrine reuptake inhibitor
by: Xiuqing Zhu, et al.
Published: (2024-11-01)

Antidepressants are selective serotonin neuronal reuptake inhibitors: 40-year history
by: D. S. Danilov
Published: (2015-03-01)

Safety and tolerability of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor antidepressants for patients with major depressive disorder
by: James M Martinez, et al.
Published: (2015-05-01)

Analytical methods for determination of selective serotonin reuptake inhibitor antidepressants
by: Şentürk Zühre, et al.
Published: (2011-06-01)

New generation of antidepressants in pregnant women
by: Ladan Kashani, et al.
Published: (2007-03-01)

Chirality of Modern Antidepressants: An Overview
by: Monica Budău, et al.
Published: (2017-12-01)

Selective serotonin reuptake inhibitor (SSRI) antidepressants, prolactin and breast cancer
by: Janet eAshbury, et al.
Published: (2012-12-01)

Chirality in Modern Antidepressants: A Comprehensive Review of Stereochemical Impacts on Pharmacology and Therapeutics
by: Gabriel Hancu, et al.
Published: (2024-09-01)

PHARMACOEPIDEMIOLOGICAL MONITORING OF ANTIDEPRESSANT USAGE IN PATIENTS WITH ANXIOUS AND DEPRESSIVE SYNDROMES IN INTERNAL MEDICINE
by: N. V. Ivanova, et al.
Published: (2015-12-01)

Effects of 071031B, a novel serotonin and norepinephrine reuptake inhibitor, on monoamine system in mice and rats
by: Rui Xue, et al.
Published: (2016-01-01)

Monoaminergic Antidepressants in the Relief of Pain: Potential Therapeutic Utility of Triple Reuptake Inhibitors (TRIs)
by: Bruno P. Guiard, et al.
Published: (2011-01-01)

Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
by: Chad Compagner, et al.
Published: (2021-01-01)

Maternal Serotonin Reuptake Inhibitor Antidepressants Have Acute Effects on Fetal Heart Rate Variability in Late Gestation
by: Kayleigh S. J. Campbell, et al.
Published: (2021-08-01)

Periodontal status in chronic periodontitis depressed patients on desvenlafaxine: An observational study
by: Anu Bhatia, et al.
Published: (2018-01-01)

Antidepressants and cardiovascular adverse events: A narrative review
by: Mohammad Hassan Nezafati, et al.
Published: (2015-09-01)

Use of serotonin reuptake inhibitor antidepressants and the risk of bleeding complications in patients on anticoagulant or antiplatelet agents: a systematic review and meta-analysis
by: Surapon Nochaiwong, et al.
Published: (2022-12-01)

Is the Antidepressant Activity of Selective Serotonin Reuptake Inhibitors Mediated by Nicotinic Acetylcholine Receptors?
by: Hugo R. Arias, et al.
Published: (2021-04-01)

Antidepressant-like drug effects in juvenile and adolescent mice in the tail suspension test: Relationship with hippocampal serotonin and norepinephrine transporter expression and function.
by: Nathan C Mitchell, et al.
Published: (2013-10-01)

The effect of selective serotonin and norepinephrine reuptake inhibitors on clinical outcome of COVID‐19 patients: A systematic review and meta‐analysis
by: Dena Firouzabadi, et al.
Published: (2022-11-01)

Antidepressants with antimicrobial activity? A promising therapeutic strategy
by: Gloria M. González, et al.
Published: (2022-07-01)

Milnacipran poorly modulates pain in patients suffering from fibromyalgia: a randomized double-blind controlled study
by: Pickering G, et al.
Published: (2018-08-01)

The use of serotonin reuptake inhibitors increases the risk of bleeding in patients with assist devices
by: Bianca Auschra, et al.
Published: (2022-03-01)

Prescribing behavior of antidepressants for depressive disorders: A systematic review
by: Mary K. Lam, et al.
Published: (2022-09-01)

Risk of stress cardiomyopathy associated with selective serotonin reuptake inhibitors and serotonin and norepinephrine reuptake inhibitors: a real-world pharmacovigilance analysis
by: Boyu Tan, et al.
Published: (2024-07-01)

The Effect of Serotonin-Norepinephrine Reuptake Inhibitor Milnacipran on Anxiety-like Behaviors in Diabetic Mice
by: Tuhfatul Ulya, et al.
Published: (2021-12-01)

Pharmacological Characterization of Toludesvenlafaxine as a Triple Reuptake Inhibitor
by: Haibo Zhu, et al.
Published: (2021-09-01)

Comparative efficacy and acceptability of selective serotonin reuptake inhibitor antidepressants for binge eating disorder: A network meta-analysis
by: Hanying Duan, et al.
Published: (2022-09-01)

Antidepressant class and concurrent rTMS outcomes in major depressive disorder: a systematic review and meta-analysisResearch in context
by: Alina Zaidi, et al.
Published: (2024-09-01)

Selective serotonin reuptake inhibitors suppress sharp wave ripples in the ventral hippocampus
by: Hiromi Shiozaki, et al.
Published: (2023-06-01)

Which adverse effects influence the dropout rate in selective serotonin reuptake inhibitor (SSRI) treatment? Results for 50,824 patients
by: Kostev, Karel, et al.
Published: (2014-10-01)

Comparative analysis of the use of selective serotonin reuptake inhibitors during pregnancy and the postpartum period. Safety of sertraline
by: E. A. Ushkalova, et al.
Published: (2023-10-01)

Bradycardia Caused by interaction of Venlafaxine and Cyclosporine: A case report
by: Marzieh Azizi, et al.
Published: (2019-09-01)

The lived experience of withdrawal from Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants: A qualitative interview study
by: Raqeeb Mahmood, et al.
Published: (2024-02-01)

Acute Angle-Closure—A Rare but Vision-Threatening Ocular Adverse Effect of Selective Serotonin Reuptake Inhibitors
by: Michał Wiciński, et al.
Published: (2021-04-01)

Antidepressant use and risk of intubation or death in hospitalized patients with COVID-19: A retrospective cohort study of clinical effectiveness
by: Brian P. Brennan, et al.
Published: (2022-09-01)

ANXIETY AND DEPRESSION IN INTERNAL MEDICINE
by: A. V. Fedotova
Published: (2016-01-01)

Serotonin reuptake inhibitors in Obsessive-Compulsive Disorder: antidepressant or antiobsessional agents?
by: Giuseppe Maina, et al.
Published: (2009-03-01)

Optimization of Nasal Liposome Formulation of Venlafaxine Hydrochloride using a Box-Behnken Experimental Design
by: Sulekha Khute, MPharm, et al.
Published: (2023-01-01)